Rate My Professor Kentaro Yomogida

Yomogida's research investigates transcription factors that regulate immune cell development and function, and how their dysregulation leads to autoimmunity, with a focus on innate lymphoid cells, juvenile idiopathic arthritis (JIA), and intestinal immunity. In the Yomogida Lab, his team explores molecular and cellular drivers of inflammation in JIA, emphasizing that pediatric autoimmune diseases follow unique pathways distinct from adults, aiming to translate discoveries into child-specific therapies. Key publications include "The transcription factor Aiolos restrains the activation of intestinal intraepithelial lymphocytes" (Nature Immunology, 2024), "Hobit confers tissue-dependent programs to type 1 innate lymphoid cells" (Proceedings of the National Academy of Sciences, 2021), "Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues" (Nature Immunology, 2019), "The aryl hydrocarbon receptor instructs the immunomodulatory profile of a subset of Clec4a4+ eosinophils unique to the small intestine" (Proceedings of the National Academy of Sciences, 2022), and "Cell penetrating recombinant Foxp3 protein enhances Treg function and ameliorates arthritis" (Biochemical and Biophysical Research Communications, 2013). He received the Tobe and Stephen E. Malawista, MD, Endowment in Academic Rheumatology from the Rheumatology Research Foundation in 2019. Yomogida mentors undergraduate and graduate students, postdoctoral fellows, research technicians, medical students, residents, and fellows in research and clinical settings. He is affiliated with the Gates Institute at CU Anschutz and presents seminars on topics such as transcriptional regulatory mechanisms of intestinal intraepithelial lymphocytes in inflammatory bowel disease.